Dartmouth-Hitchcock logo
Back
 
DOAC Therapy for VTE Management

This 1-hour seminar will provide clinical guidance on direct oral anticoagulants, which provide a treatment alternative to warfarin for select patients. Topics include indications, risks and benefits, drug selection and dosing.

Activity Details
Start Date: October 23, 2017
End Date: October 23, 2020
Link: View Presentation
Registration

There is no fee for this activity, but to receive credit you must register online and complete the online evaluation (you must register to access).

Learning Outcome(s)

At the conclusion of this learning activity, participants will be able to apply new knowledge to enhance clinical practice in the care of patients being considered for DOAC drugs including indications, risks and benefits, drug selection and dosing.

Accreditation

Dartmouth-Hitchcock is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Dartmouth-Hitchcock designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Requirements for Successful Completion

In order to receive credit for this Continuing Medical Education (CME) activity, you must:

  • View the entire presentation
  • Complete the activity evaluation. (you must register to access).
Speaker Disclosure

In accordance with the disclosure policy of Dartmouth-Hitchcock/Geisel School of Medicine at Dartmouth as well as standards set forth by the Accreditation Council on Continuing Medical Education and the Nursing Continuing Education Council standards set forth by the American Nurses Credentialing Center Commission on Accreditation, continuing medical education and nursing education activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have been asked to disclose any financial relationship* they have to a commercial interest (any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients). Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide participants with information that might be of potential importance to their evaluation of a given activity.

The activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content for DOAC Therapy for VTE Management, have reported NO financial interest or relationship* with various companies. There were no individuals in a position to control the content that refused to disclose.

*A “financial interest or relationship" refers to an equity position, receipt of royalties, consultantship, funding by a research grant, receiving honoraria for educational services elsewhere, or to any other relationship to a company that provides sufficient reason for disclosure, in keeping with the spirit of the stated policy.

Provider Contact Information

Provider contact information for questions regarding accreditation of the activity:
Center for Learning and Professional Development
Dartmouth-Hitchcock Medical Center
clpd.support@hitchcock.org

For more information on this topic, please view the activity references list.


Type:     Internet Activity (Enduring Material)
35 Registered Users

0